Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis.

Current opinion in obstetrics & gynecology - 1 Feb 2011

Liu Naifu, Wang Xingwu, Sheng Xiugui

Abstract excerpt

PURPOSE OF REVIEW: To summarize the recent evidence for 'triple negative' epithelial ovarian cancer (TNEOC), characterized by lack of expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor type 2 (HER2), and to discuss its potential pathologic markers for prognosis and targeted therapy. RECENT FINDINGS: 'Triple negative' phenotype is traditionally referred to as a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ovarian Epithelial
Share to Clinical Trials, Phase I as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase II as Topic

Share to Evidence-Based Medicine

Share to Neoplasms, Glandular and Epithelial

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 21150601
DOI: 10.1097/GCO.0b013e32834252f5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

'Triple negative' epithelial ovarian cancer and pathologic markers for prognosis.PMID 21150601Read ↗

Molecular targets and therapies associated with poor prognosis of triple‑negative breast cancer (Review)Semantic proximity Read ↗

Triple negative breast cancer: unmet medical needs.Semantic proximity Read ↗

Triple-negative breast cancer and the need for new therapeutic targets.Semantic proximity Read ↗

[Triple-negative breast cancer: molecular characteristics and potential therapeutic approaches].Semantic proximity Read ↗

Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment.Semantic proximity Read ↗

Biology and Management of Patients With Triple-Negative Breast CancerSemantic proximity Read ↗

Integrated molecular characterisation of endometrioid ovarian carcinoma identifies opportunities for stratificationSemantic proximity Read ↗

New targets for triple-negative breast cancer.Semantic proximity Read ↗

Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast CancerSemantic proximity Read ↗

Triple-negative breast cancer.Semantic proximity Read ↗

Triple-negative Breast Carcinoma: Morphologic and Molecular Subtypes.Semantic proximity Read ↗

Triple-negative breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.